32 Stocks Moving In Monday's Mid-Day Session

Gainers

• Regional Health Properties, Inc. RHE shares jumped 99.7% to $14.42 after jumping 38% on Friday.
• Brooklyn ImmunoTherapeutics, Inc. BTX gained 30.5% to $64.99 as the stock continued to increase in popularity on the subreddit r/wallstreetbets. On Friday, Brooklyn ImmunoTherapeutics filed a Form 8-K showing that it entered into a purchase agreement with Lincoln Park Capital on Apr. 26 in which the company can sell up to $20 million of common shares to the Chicago-based investment group and asset management firm. Additionally, Nicholas J Singer disclosed that he took a 9%-plus stake in the company in a 13G filing on Friday.
• Rezolute, Inc. RZLT surged 30.3% to $8.15. Rezolute, last month, announced $30 million debt financing agreement with SLR Capital Partners.
• Milestone Scientific Inc. MLSS gained 22.6% to $3.09. Milestone Scientific reported preliminary Q1 sales of $2.9 million up from $1.8 million.
• Scully Royalty Ltd. SRL shares climbed 21.5% to $12.96. Scully Royalty said it has 'taken the first step by approving a policy for future cash dividends.' However, no dividends have been declared or determined to date.
• Ocugen, Inc. OCGN gained 19.2% to $15.10 after the company announced that in a new study, COVAXIN demonstrated potential effectiveness against the Brazil variant of SARS-CoV-2, B.1.128.2.
• Friedman Industries, Incorporated FRD surged 18% to $9.63.
• Novo Integrated Sciences, Inc. NVOS gained 16% to $3.0648.
• Farmmi, Inc. FAMI rose 15.4% to $00.5145 after jumping around 25% on Friday. The company, last week, announced it priced its 140 million common stock offering $0.30 per share.
• Nisun International Enterprise Development Group Co., Ltd NISN gained 14.7% to $17.22 following FY20 results. The company reported FY20 sales of $10.78 million, up from $2.5 million year over year.
• GeoVax Labs, Inc. GOVX shares rose 13.3% to $6.17. GeoVax is expected to report Q1 results on May 6.
• Ashford Hospitality Trust, Inc. AHT shares rose 13% to $3.10 after jumping over 13% on Friday.
• Peabody Energy Corporation BTU gained 12.7% to $4.17. Peabody Energy dropped 9% on Friday following quarterly results.
• Image Sensing Systems, Inc. ISNS gained 11.5% to $7.27. Image Sensing Systems shares jumped 42% on Friday after the company announced it initiated a quarterly dividend of $0.12 per share, authorized a 220,000 share buyback and announced the implementation of a holding company reorganization.
• Olympic Steel, Inc. ZEUS surged 11.4% to $32.35.
• Danaos Corporation DAC gained 10.3% to $59.90.
• Silvercorp Metals Inc. SVM rose 8.9% to $5.75.
• Aesthetic Medical International Holdings Group Limited AIH gained 5.7% to $7.08 as the company released 20-F late Friday.
• DAVIDsTEA Inc. DTEA rose 4.2% to $3.4899 following quarterly results. The company reported Q4 adjusted earnings of $0.15 per share, up from $0.13 per share in the year-ago quarter. Its total sales fell 45.3% to $40.2 million, while sales from e-commerce and wholesale channels jumped by 95.9% during the quarter.

Check out these big penny stock gainers and losers

Losers

• Vaxart, Inc. VXRT shares dipped 18% to $8.84 after the company reported a wider Q1 loss.
• Novavax, Inc. NVAX dropped 13.5% to $204.96 despite the company initiating a pediatric expansion for its COVID-19 vaccine trial. Weakness is potentially due to profit taking after the stock surged last week following multiple positive catalysts.
• EHang Holdings Limited EH fell 12.1% to $24.52. EHang, last week, reported worse-than-expected Q4 results.
• Humanigen, Inc. HGEN fell 11.5% to $17.05. Humanigen, last month, announced data from the Phase 1b portion of the ZUMA-19 trial evaluating its lead candidate lenzilumab in patients treated with CAR-T in diffuse large B-cell lymphoma (DLBCL).
• Versus Systems Inc. VS shares declined 11.3% to $8.56. Versus Systems is expected to host an Interactive Investor Event on May 20th.
• AVROBIO, Inc. AVRO fell 11.1% to $10.38 after the company provided an update on its regulatory plans for AVR-RD-01, its lentiviral gene therapy for Fabry disease, currently in FAB-GT Phase 2 trial.
• Evelo Biosciences, Inc. EVLO dropped 11.1% to $11.69. Morgan Stanley maintained Evelo Biosciences with an Equal-Weight and lowered the price target from $14 to $13.
• MicroVision, Inc. MVIS shares fell 10.6% to $13.63.
• BBQ Holdings, Inc. BBQ dropped 10.1% to $11.86.
• The9 Limited NCTY shares declined 9.1% to $20.88.
• Galectin Therapeutics Inc. GALT fell 8.8% to $4.03.
• Pacific Biosciences of California, Inc. PACB shares fell 8.5% to $27.30. The company, last week, reported Q1 results.